Envometinib
Envometinib (Compound B) is a dual-MEK inhibitor that works through Deep Cyclic Inhibition (DCI). Envometinib has antitumor activity in various in vivo models. Envometinib can be studied in RAS and RAF mutated cancer such as colorectal cancer and melanoma.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 2952542-22-0
- Formule: C23H27ClN4O6S
- Masse moléculaire:523.00
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Protocole
- Pureté et documentation
- Références
-
Help & FAQs
Voir tous les produits spécifiques à Isoform MEK
More
Activité biologique
Description
Chemical Information
-
CAS No. 2952542-22-0
-
Masse moléculaire 523.00
-
Formule C23H27ClN4O6S
-
SMILES
CN(CC(C1=C(OC2=O)C=C(OC(N(C)C)=O)C=C1)=C2CC3=C(C(NS(NC)(=O)=O)=CC=C3)Cl)C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Envometinib Related Classifications
HY-177081 Related Classifications
Powered by Bioz